stockrowBeam Therapeutics Inc.
BEAM Healthcare Biotechnology
Beam Therapeutics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $139.7 million, up 120.0% from fiscal 2024.
- Revenue
- −96.8%
- EPS
- −16.7%
- Free cash flow
- −29.5%
Quarter to September 2026, against a year earlier
Follow BEAM
Alert me
Beam Therapeutics Inc. (BEAM) Operating margin
Beam Therapeutics Inc.'s operating margin over the twelve months to 30 September 2026 was −267.7%, up 6.9 percentage points from fiscal 2025 (−274.6%). Over the past ten years it has ranged from −553,166.7% (fiscal 2020) to 0.00% (fiscal 2018); the current reading is higher than 67% of that period. That is below the Biotechnology industry median of 0.00% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | −274.6% | 379.68 |
| FY2024 | −654.3% | (607.52) |
| FY2023 | −46.7% | 508.88 |
| FY2022 | −555.6% | 201.40 |
| FY2021 | −757.0% | 552,409.66 |
| FY2020 | −553,166.7% | (135,644.45) |
| FY2019 | −417,522.2% | (417,522.22) |
| FY2018 | 0.00% | 0.00 |
| FY2017 | 0.00% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | −46,033.2% | (20,206.08) |
| Jun 2026 | −25,827.1% | (25,489.33) |
| Mar 2026 | −337.8% | (322.52) |
| Dec 2025 | −15.3% | 1,292.31 |
| 27 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| MBX MBX Biosciences, Inc. compare | 0.00% |
| ZLAB Zai Lab Limited Unsponsored ADR compare | −63.0% |
| XNCR Xencor, Inc. compare | −205.8% |
| BEAM Beam Therapeutics Inc. | −267.7% |
| RCUS Arcus Biosciences, Inc. compare | −475.0% |
| NAMS NewAmsterdam Pharma Company N.V. compare | −900.1% |
| IDYA IDEAYA Biosciences, Inc. compare | −1,267.4% |
| VRDN Viridian Therapeutics, Inc. compare | −1,781.4% |
| TLX Telix Pharmaceuticals Limited compare | — |
| Biotechnology industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on BEAM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- The full statement